Inuvo Inc (AMEX:INUV) does about 796.49K shares in volume on a normal day but saw 2023252 shares change hands in the recent trading day. The company now has a market cap of 53.93M USD. Its current market price is $0.38, marking an increase of 8.42% compared to the previous close of $0.35. The 52 week high reached by this stock is $0.57 whilst the lowest price level in 52 weeks is $0.19.
Inuvo Inc (INUV) has a 20-day trading average at $0.3069 and the current price is -32.67% off the 52-week high compared with 102.00% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2645 and its 200-day simple moving average is $0.2951. If we look at the stock’s price movements over the week, volatility stands at 10.75%, which increases to 13.96% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 67.33 to suggest the stock is neutral.
The consensus objective for the share price is $0.95, suggesting that the stock has a potential upside of 60.0% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 28, 2020 when Alliance Global Partners initiated the stock to “Buy” and issued a price target of $2.25. ROTH Capital initiated its price target at $4.50.
The current price level is 25.07%, 45.09%, and 30.08% away from its SMA20, SMA50, and SMA200 respectively, with the INUV price moving below the 50-day SMA on current market day. Inuvo Inc (INUV) stock is up 10.61% over the week and 89.44% over the past month. Its price is -9.69% year-to-date and 10.41% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.0 and -0.04 for whole year. Expected sales for next quarter are $19.13M, which analysts say will come at $82.89M for the current fiscal year and next year at $106.05M. In addition, estimates put the company’s current quarterly revenue at an average of $25.28M.
To reach the target analysts have set, the stock logically needs to grow 60.0 percent from here.
The company has a return on investment of -62.87% and return on equity of -53.11%. The beta has a value of 1.20. Price to book ratio is 4.35 and price to sales ratio is 0.69.
